Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,19101917,migration times,"The migration times for procaine and tetracaine were 1.25 and 1.36 min, respectively.",Rapid analysis of tetracaine for a tape stripping pharmacokinetic study using short-end capillary electrophoresis. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19101917/),min,1.25,27204,DB00721,Procaine
,19101917,migration times,"The migration times for procaine and tetracaine were 1.25 and 1.36 min, respectively.",Rapid analysis of tetracaine for a tape stripping pharmacokinetic study using short-end capillary electrophoresis. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19101917/),min,1.36,27205,DB00721,Procaine
greater,19101917,signal-to-noise ratio,"The limit of quantification for tetracaine was 50 microg, with a signal-to-noise ratio greater than 10.",Rapid analysis of tetracaine for a tape stripping pharmacokinetic study using short-end capillary electrophoresis. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19101917/),,10,27206,DB00721,Procaine
>,19101917,recovery,The absolute mean recovery of tetracaine was >97%.,Rapid analysis of tetracaine for a tape stripping pharmacokinetic study using short-end capillary electrophoresis. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19101917/),%,97,27207,DB00721,Procaine
,2704057,peak penicillin concentration,"A subconjunctival injection of procaine penicillin at a dose of 6 X 10(5) iu in 2 ml, administered either through the skin or through the conjunctiva, produced a peak penicillin concentration in the CF of approximately 8 iu/ml for either route and a duration of therapeutic concentration (DTC) of 67.6 +/- 4.9 and 40 +/- 2.7 h respectively.",The concentration of penicillin in bovine conjunctival sac fluid as it pertains to the treatment of Moraxella bovis infection. (I) Subconjunctival injection. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2704057/),[iu] / [ml],8,30311,DB00721,Procaine
,2704057,duration of therapeutic concentration (DTC),"A subconjunctival injection of procaine penicillin at a dose of 6 X 10(5) iu in 2 ml, administered either through the skin or through the conjunctiva, produced a peak penicillin concentration in the CF of approximately 8 iu/ml for either route and a duration of therapeutic concentration (DTC) of 67.6 +/- 4.9 and 40 +/- 2.7 h respectively.",The concentration of penicillin in bovine conjunctival sac fluid as it pertains to the treatment of Moraxella bovis infection. (I) Subconjunctival injection. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2704057/),h,67.6,30312,DB00721,Procaine
,2704057,duration of therapeutic concentration (DTC),"A subconjunctival injection of procaine penicillin at a dose of 6 X 10(5) iu in 2 ml, administered either through the skin or through the conjunctiva, produced a peak penicillin concentration in the CF of approximately 8 iu/ml for either route and a duration of therapeutic concentration (DTC) of 67.6 +/- 4.9 and 40 +/- 2.7 h respectively.",The concentration of penicillin in bovine conjunctival sac fluid as it pertains to the treatment of Moraxella bovis infection. (I) Subconjunctival injection. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2704057/),h,40,30313,DB00721,Procaine
,677541,half-life,"The elimination of the antibiotic followed first-order kinetics, and the half-life was found to be 0.5 hours.",Pharmacokinetics of penicillin G in the turkey. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/677541/),h,0.5,35447,DB00721,Procaine
,1582389,detection time,"Similarly, peak urinary procaine concentrations were attained within 1.5 to 3 h, irrespective of dose, while detection time was dose-dependent, being 23 h for 80-200 mg doses but as long as 30-54 h with the 1600 mg dose.",Plasma elimination and urinary excretion of procaine after administration of different products to standardbred mares. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1582389/),h,23,36849,DB00721,Procaine
,1582389,detection time,"Similarly, peak urinary procaine concentrations were attained within 1.5 to 3 h, irrespective of dose, while detection time was dose-dependent, being 23 h for 80-200 mg doses but as long as 30-54 h with the 1600 mg dose.",Plasma elimination and urinary excretion of procaine after administration of different products to standardbred mares. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1582389/),h,30-54,36850,DB00721,Procaine
,10895905,elimination phase half-lives,"Median elimination phase half-lives of penicillin G were 24.7 and 12.9 hours, respectively, after administration of PGP and penicillin G potassium.",Pharmacokinetics of penicillin G procaine versus penicillin G potassium and procaine hydrochloride in horses. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/10895905/),h,24.7,41599,DB00721,Procaine
,10895905,elimination phase half-lives,"Median elimination phase half-lives of penicillin G were 24.7 and 12.9 hours, respectively, after administration of PGP and penicillin G potassium.",Pharmacokinetics of penicillin G procaine versus penicillin G potassium and procaine hydrochloride in horses. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/10895905/),h,12.9,41600,DB00721,Procaine
,10895905,elimination phase half-life,Median elimination phase half-life of procaine following administration of PGP (15.6 hours) was significantly longer than value obtained after administration of penicillin G potassium and PH (1 hour).,Pharmacokinetics of penicillin G procaine versus penicillin G potassium and procaine hydrochloride in horses. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/10895905/),h,15.6,41601,DB00721,Procaine
,10895905,elimination phase half-life,Median elimination phase half-life of procaine following administration of PGP (15.6 hours) was significantly longer than value obtained after administration of penicillin G potassium and PH (1 hour).,Pharmacokinetics of penicillin G procaine versus penicillin G potassium and procaine hydrochloride in horses. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/10895905/),h,1,41602,DB00721,Procaine
,2704059,synovial fluid:serum area under curve (AUC) ratio,"Of the two penicillin G preparations, PPG gave a significantly higher synovial fluid:serum area under curve (AUC) ratio than did KPG; 0.76 +/- 0.10 and 0.54 +/- 0.12, respectively (P less than 0.05).","Concentrations of sulphadimidine, oxytetracycline and penicillin G in serum, synovial fluid and tissue cage fluid after parenteral administration to calves. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2704059/),,0.76,52886,DB00721,Procaine
,2704059,synovial fluid:serum area under curve (AUC) ratio,"Of the two penicillin G preparations, PPG gave a significantly higher synovial fluid:serum area under curve (AUC) ratio than did KPG; 0.76 +/- 0.10 and 0.54 +/- 0.12, respectively (P less than 0.05).","Concentrations of sulphadimidine, oxytetracycline and penicillin G in serum, synovial fluid and tissue cage fluid after parenteral administration to calves. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2704059/),,0.54,52887,DB00721,Procaine
,2704059,synovial fluid:serum AUC-ratio,"For OTC, the synovial fluid:serum AUC-ratio was 0.33 +/- 0.12 after i.m. and 0.34 +/- 0.08 after i.v. administration.","Concentrations of sulphadimidine, oxytetracycline and penicillin G in serum, synovial fluid and tissue cage fluid after parenteral administration to calves. ",AUCR-Q21,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2704059/),,0.33,52888,DB00721,Procaine
,2704059,synovial fluid:serum AUC-ratio,"For OTC, the synovial fluid:serum AUC-ratio was 0.33 +/- 0.12 after i.m. and 0.34 +/- 0.08 after i.v. administration.","Concentrations of sulphadimidine, oxytetracycline and penicillin G in serum, synovial fluid and tissue cage fluid after parenteral administration to calves. ",AUCR-Q21,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2704059/),,0.34,52889,DB00721,Procaine
,2882974,Basal bile flow rates,Basal bile flow rates were increased by 62% after the induction of diabetes to 88 microliter/min/kg.,Alterations in biliary excretory function by streptozotocin-induced diabetes. ,Q-Q54,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2882974/),[μl] / [kg·min],88,56721,DB00721,Procaine
,8706643,peak concentration,"Free unconjugated procaine in equine urine reached a peak concentration of 23.7 ng/mL, while total (unconjugated plus conjugated) procaine peaked at 37.9 ng/mL (mean urine pH of 8.5).",Regulatory significance of procaine residues in plasma and urine samples: preliminary communication. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8706643/),[ng] / [ml],23.7,96908,DB00721,Procaine
,8706643,peak concentration,"Free unconjugated procaine in equine urine reached a peak concentration of 23.7 ng/mL, while total (unconjugated plus conjugated) procaine peaked at 37.9 ng/mL (mean urine pH of 8.5).",Regulatory significance of procaine residues in plasma and urine samples: preliminary communication. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8706643/),[ng] / [ml],37.9,96909,DB00721,Procaine
,8706643,duration of effect,There was a significant local anaesthetic (LA) effect for all doses of procaine HCl with the duration of effect ranging from 30 min (40 mg) to 60 min (320 mg).,Regulatory significance of procaine residues in plasma and urine samples: preliminary communication. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8706643/),min,30,96910,DB00721,Procaine
,8706643,duration of effect,There was a significant local anaesthetic (LA) effect for all doses of procaine HCl with the duration of effect ranging from 30 min (40 mg) to 60 min (320 mg).,Regulatory significance of procaine residues in plasma and urine samples: preliminary communication. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8706643/),,60,96911,DB00721,Procaine
,11497050,highest concentrations,"The highest concentrations of penicillin G in plasma, kidney, and liver were 13 ng/ml, 92 ng/g, and 142 ng/g, respectively.",Tissue disposition and depletion of penicillin G after oral administration with milk in unweaned dairy calves. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11497050/),[ng] / [ml],13,105051,DB00721,Procaine
,11497050,highest concentrations,"The highest concentrations of penicillin G in plasma, kidney, and liver were 13 ng/ml, 92 ng/g, and 142 ng/g, respectively.",Tissue disposition and depletion of penicillin G after oral administration with milk in unweaned dairy calves. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11497050/),[ng] / [g],92,105052,DB00721,Procaine
,11497050,highest concentrations,"The highest concentrations of penicillin G in plasma, kidney, and liver were 13 ng/ml, 92 ng/g, and 142 ng/g, respectively.",Tissue disposition and depletion of penicillin G after oral administration with milk in unweaned dairy calves. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11497050/),[ng] / [g],142,105053,DB00721,Procaine
,2014157,plasma t1/2,"After intraperitoneal injection of 50 mumols/kg, the plasma t1/2 of cocaine was 21 +/- 5 min and peak plasma concentration (1682 +/- 260 pmol/mL, measured by HPLC) was achieved in 5-10 min; a lower peak plasma concentration (486 +/- 103 pmol/mL) was achieved in 20-60 min after s.c. injection.",Effects of cocaine on rat embryo development in vivo and in cultures. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2014157/),min,21,106641,DB00721,Procaine
,2014157,peak plasma concentration,"After intraperitoneal injection of 50 mumols/kg, the plasma t1/2 of cocaine was 21 +/- 5 min and peak plasma concentration (1682 +/- 260 pmol/mL, measured by HPLC) was achieved in 5-10 min; a lower peak plasma concentration (486 +/- 103 pmol/mL) was achieved in 20-60 min after s.c. injection.",Effects of cocaine on rat embryo development in vivo and in cultures. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2014157/),[pM] / [ml],1682,106642,DB00721,Procaine
,2014157,peak plasma concentration,"After intraperitoneal injection of 50 mumols/kg, the plasma t1/2 of cocaine was 21 +/- 5 min and peak plasma concentration (1682 +/- 260 pmol/mL, measured by HPLC) was achieved in 5-10 min; a lower peak plasma concentration (486 +/- 103 pmol/mL) was achieved in 20-60 min after s.c. injection.",Effects of cocaine on rat embryo development in vivo and in cultures. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2014157/),[pM] / [ml],486,106643,DB00721,Procaine
,32943077,maximum plasma concentration (Cmax),"After intravenous administration of benzylpenicillin (n = 6), maximum plasma concentration (Cmax), 1860-9318 µg/L, was observed after 15 min.",Exposure to benzylpenicillin after different dosage regimens in growing pigs. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/32943077/),[μg] / [l],1860-9318,108382,DB00721,Procaine
,32943077,Cmax,"After intramuscular administration of ETH (n = 6) Cmax, 1000-4270 µg/L, was observed within one h (tmax) in 5 pigs but at four h in one pig.",Exposure to benzylpenicillin after different dosage regimens in growing pigs. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/32943077/),[μg] / [l],1000-4270,108383,DB00721,Procaine
,32943077,tmax,"After intramuscular administration of ETH (n = 6) Cmax, 1000-4270 µg/L, was observed within one h (tmax) in 5 pigs but at four h in one pig.",Exposure to benzylpenicillin after different dosage regimens in growing pigs. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/32943077/),h,one,108384,DB00721,Procaine
,32943077,Cmax,"Cmax for UPA (n = 6), 910-3220 µg/L, was observed within one h in three pigs, but at four or 24 h in three pigs.",Exposure to benzylpenicillin after different dosage regimens in growing pigs. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/32943077/),[μg] / [l],910-3220,108385,DB00721,Procaine
,32943077,MIC,"Repeated administration of different dosages of ETH and UPA in pigs inoculated with A. pleuropneumoniae (n = 54) showed that the approved dose for UPA (30 mg/kg, qd) but not for ETH (20 mg/kg, qd) gave adequate plasma exposure for bacteria with a penicillin MIC of 500 µg/L.",Exposure to benzylpenicillin after different dosage regimens in growing pigs. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/32943077/),[μg] / [l],500,108386,DB00721,Procaine
,32943077,MIC,The approved dosage of ETH provided insufficient plasma exposure for adequate therapy of infections caused by A. pleuropneumoniae or other bacteria with a penicillin MIC of 500 µg/L.,Exposure to benzylpenicillin after different dosage regimens in growing pigs. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/32943077/),[μg] / [l],500,108387,DB00721,Procaine
,11442793,area under the concentration-time curve (AUC),"For i.v. administration, the area under the concentration-time curve (AUC), 7456 and 5508 ng/mL h, and systemic clearance, 0.54 and 0.73 L/kg h, were significantly different (P < 0.05) at 1 and 5 weeks of age, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,AUCinf-Q17,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),[ng] / [h·ml],7456,110651,DB00721,Procaine
,11442793,area under the concentration-time curve (AUC),"For i.v. administration, the area under the concentration-time curve (AUC), 7456 and 5508 ng/mL h, and systemic clearance, 0.54 and 0.73 L/kg h, were significantly different (P < 0.05) at 1 and 5 weeks of age, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,AUCinf-Q17,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),[ng] / [h·ml],5508,110652,DB00721,Procaine
,11442793,systemic clearance,"For i.v. administration, the area under the concentration-time curve (AUC), 7456 and 5508 ng/mL h, and systemic clearance, 0.54 and 0.73 L/kg h, were significantly different (P < 0.05) at 1 and 5 weeks of age, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),[l] / [h·kg],0.54,110653,DB00721,Procaine
,11442793,systemic clearance,"For i.v. administration, the area under the concentration-time curve (AUC), 7456 and 5508 ng/mL h, and systemic clearance, 0.54 and 0.73 L/kg h, were significantly different (P < 0.05) at 1 and 5 weeks of age, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),[l] / [h·kg],0.73,110654,DB00721,Procaine
,11442793,AUC,"Following oral (p.o.) administration, there were significant differences (P < 0.01) at 1 and 5 weeks of age in the AUC, 760 and 409 ng/mL h, terminal half-life, 2.1 and 1.6 h, time of maximum concentration (TMAX), 3.0 and 2.3 h, and maximum plasma concentration (CMAX), 85 and 58 ng/mL, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,AUCinf-Q17,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),[ng] / [h·ml],760,110655,DB00721,Procaine
,11442793,AUC,"Following oral (p.o.) administration, there were significant differences (P < 0.01) at 1 and 5 weeks of age in the AUC, 760 and 409 ng/mL h, terminal half-life, 2.1 and 1.6 h, time of maximum concentration (TMAX), 3.0 and 2.3 h, and maximum plasma concentration (CMAX), 85 and 58 ng/mL, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,AUCinf-Q17,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),[ng] / [h·ml],409,110656,DB00721,Procaine
,11442793,terminal half-life,"Following oral (p.o.) administration, there were significant differences (P < 0.01) at 1 and 5 weeks of age in the AUC, 760 and 409 ng/mL h, terminal half-life, 2.1 and 1.6 h, time of maximum concentration (TMAX), 3.0 and 2.3 h, and maximum plasma concentration (CMAX), 85 and 58 ng/mL, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),h,2.1,110657,DB00721,Procaine
,11442793,terminal half-life,"Following oral (p.o.) administration, there were significant differences (P < 0.01) at 1 and 5 weeks of age in the AUC, 760 and 409 ng/mL h, terminal half-life, 2.1 and 1.6 h, time of maximum concentration (TMAX), 3.0 and 2.3 h, and maximum plasma concentration (CMAX), 85 and 58 ng/mL, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),h,1.6,110658,DB00721,Procaine
,11442793,time of maximum concentration (TMAX),"Following oral (p.o.) administration, there were significant differences (P < 0.01) at 1 and 5 weeks of age in the AUC, 760 and 409 ng/mL h, terminal half-life, 2.1 and 1.6 h, time of maximum concentration (TMAX), 3.0 and 2.3 h, and maximum plasma concentration (CMAX), 85 and 58 ng/mL, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),h,3.0,110659,DB00721,Procaine
,11442793,time of maximum concentration (TMAX),"Following oral (p.o.) administration, there were significant differences (P < 0.01) at 1 and 5 weeks of age in the AUC, 760 and 409 ng/mL h, terminal half-life, 2.1 and 1.6 h, time of maximum concentration (TMAX), 3.0 and 2.3 h, and maximum plasma concentration (CMAX), 85 and 58 ng/mL, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),h,2.3,110660,DB00721,Procaine
,11442793,maximum plasma concentration (CMAX),"Following oral (p.o.) administration, there were significant differences (P < 0.01) at 1 and 5 weeks of age in the AUC, 760 and 409 ng/mL h, terminal half-life, 2.1 and 1.6 h, time of maximum concentration (TMAX), 3.0 and 2.3 h, and maximum plasma concentration (CMAX), 85 and 58 ng/mL, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),[ng] / [ml],85,110661,DB00721,Procaine
,11442793,maximum plasma concentration (CMAX),"Following oral (p.o.) administration, there were significant differences (P < 0.01) at 1 and 5 weeks of age in the AUC, 760 and 409 ng/mL h, terminal half-life, 2.1 and 1.6 h, time of maximum concentration (TMAX), 3.0 and 2.3 h, and maximum plasma concentration (CMAX), 85 and 58 ng/mL, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),[ng] / [ml],58,110662,DB00721,Procaine
,11442793,Bioavailability,"Bioavailability was 10.2 and 7.4% at 1 and 5 weeks, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),%,10.2,110663,DB00721,Procaine
,11442793,Bioavailability,"Bioavailability was 10.2 and 7.4% at 1 and 5 weeks, respectively.",Bioavailability and disposition of sodium and procaine penicillin G (benzylpenicillin) administered orally with milk to calves. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11442793/),%,7.4,110664,DB00721,Procaine
greater,2976206,peak serum levels,"Trospectomycin, when given in single doses exceeding 40 mg/kg, surpassed penicillin in peak serum levels (greater than 60 micrograms/ml at 1 hr) but not in duration of activity.",Tissue fluid penetration and anti-treponemal activity of trospectomycin (a new spectinomycin analog) in the rabbit syphilis model. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2976206/),[μg] / [ml],60,112175,DB00721,Procaine
,573562,distribution half-life (t1/2 alpha),Following termination of the infusion the drug disappeared with a distribution half-life (t1/2 alpha) of 2.49 +/- 0.36 minutes and an elimination half-life (t1/2 beta) of 7.69 +/- 0.99 minutes at both infusion rates.,Pharmacokinetics of intravenous procaine infusion in humans. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/573562/),min,2.49,112980,DB00721,Procaine
,573562,elimination half-life (t1/2 beta),Following termination of the infusion the drug disappeared with a distribution half-life (t1/2 alpha) of 2.49 +/- 0.36 minutes and an elimination half-life (t1/2 beta) of 7.69 +/- 0.99 minutes at both infusion rates.,Pharmacokinetics of intravenous procaine infusion in humans. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/573562/),min,7.69,112981,DB00721,Procaine
,573562,volume of distribution at steady-state,"In group I, the fraction of drug in the central compartment was 65%, the volume of distribution at steady-state was 0.79 +/- 0.14 L/kg, and total body clearance 0.08 +/- 0.01 L/kg/min.",Pharmacokinetics of intravenous procaine infusion in humans. ,Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/573562/),[l] / [kg],0.79,112982,DB00721,Procaine
,573562,total body clearance,"In group I, the fraction of drug in the central compartment was 65%, the volume of distribution at steady-state was 0.79 +/- 0.14 L/kg, and total body clearance 0.08 +/- 0.01 L/kg/min.",Pharmacokinetics of intravenous procaine infusion in humans. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/573562/),[l] / [kg·min],0.08,112983,DB00721,Procaine
,573562,fraction of drug in the central compartment,"In group II, the fraction of drug in the central compartment was 82%, the volume of distribution at steady-state 0.34 +/- 0.07 L/kg, and the total body clearance 0.04 +/- 0.01 L/kg/min.",Pharmacokinetics of intravenous procaine infusion in humans. ,V1-Q63,[Article Link](https://pubmed.ncbi.nlm.nih.gov/573562/),%,82,112984,DB00721,Procaine
,573562,volume of distribution at steady-state,"In group II, the fraction of drug in the central compartment was 82%, the volume of distribution at steady-state 0.34 +/- 0.07 L/kg, and the total body clearance 0.04 +/- 0.01 L/kg/min.",Pharmacokinetics of intravenous procaine infusion in humans. ,Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/573562/),[l] / [kg],0.34,112985,DB00721,Procaine
,573562,total body clearance,"In group II, the fraction of drug in the central compartment was 82%, the volume of distribution at steady-state 0.34 +/- 0.07 L/kg, and the total body clearance 0.04 +/- 0.01 L/kg/min.",Pharmacokinetics of intravenous procaine infusion in humans. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/573562/),[l] / [kg·min],0.04,112986,DB00721,Procaine
,10965422,retention times,"The retention times of the internal standard (procaine), desmethyl-trimebutine and trimebutine were 2.4, 4.3 and 6.5 min, respectively.",Determination of trimebutine and desmethyl-trimebutine in human plasma by HPLC. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10965422/),min,2.4,130093,DB00721,Procaine
,10965422,retention times,"The retention times of the internal standard (procaine), desmethyl-trimebutine and trimebutine were 2.4, 4.3 and 6.5 min, respectively.",Determination of trimebutine and desmethyl-trimebutine in human plasma by HPLC. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10965422/),min,4.3,130094,DB00721,Procaine
,10965422,retention times,"The retention times of the internal standard (procaine), desmethyl-trimebutine and trimebutine were 2.4, 4.3 and 6.5 min, respectively.",Determination of trimebutine and desmethyl-trimebutine in human plasma by HPLC. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10965422/),min,6.5,130095,DB00721,Procaine
,10965422,extraction recoveries,The extraction recoveries obtained for trimebutine and desmethyl-trimebutine were about 90%.,Determination of trimebutine and desmethyl-trimebutine in human plasma by HPLC. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10965422/),%,90,130096,DB00721,Procaine
≤,30387161,MIC90,The MIC90 of penicillin for 264 isolates of Streptococcus sp. was ≤0.06 μg/ml.,Evaluation of plasma concentration after intravenous and intramuscular penicillin administration over 24 hr in healthy adult horses. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30387161/),[μg] / [ml],0.06,133733,DB00721,Procaine
,24861750,flow rate,"The flow rate was 1 mL/min, with detection at 312 nm.",Development of HPLC-UV method for rapid and sensitive analysis of topically applied tetracaine: its comparison with a CZE method. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24861750/),[ml] / [min],1,137144,DB00721,Procaine
>,24861750,recovery,The absolute mean recovery of tetracaine was >92%.,Development of HPLC-UV method for rapid and sensitive analysis of topically applied tetracaine: its comparison with a CZE method. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24861750/),%,92,137145,DB00721,Procaine
,23419937,half-life,"The half-life of Na-pc was 1.9h, peak concentration was 14,600 ng/mL reached after about 23 min.",Intramuscular administration of sodium benzylpenicillin in horses as an alternative to procaine benzylpenicillin. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23419937/),h,1.9,177807,DB00721,Procaine
,23419937,peak concentration,"The half-life of Na-pc was 1.9h, peak concentration was 14,600 ng/mL reached after about 23 min.",Intramuscular administration of sodium benzylpenicillin in horses as an alternative to procaine benzylpenicillin. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23419937/),[ng] / [ml],"14,600",177808,DB00721,Procaine
,23419937,Trough plasma concentration,Trough plasma concentration was 281 ng/mL and protein binding 62.8%.,Intramuscular administration of sodium benzylpenicillin in horses as an alternative to procaine benzylpenicillin. ,Ctrough-Q37,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23419937/),[ng] / [ml],281,177809,DB00721,Procaine
,23419937,protein binding,Trough plasma concentration was 281 ng/mL and protein binding 62.8%.,Intramuscular administration of sodium benzylpenicillin in horses as an alternative to procaine benzylpenicillin. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23419937/),%,62.8,177810,DB00721,Procaine
,23419937,fT>MIC,The fT>MIC for Staphylococcus aureus was 63% and 100% for Streptococcus equi subsp.,Intramuscular administration of sodium benzylpenicillin in horses as an alternative to procaine benzylpenicillin. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23419937/),%,63,177811,DB00721,Procaine
,23419937,fT>MIC,The fT>MIC for Staphylococcus aureus was 63% and 100% for Streptococcus equi subsp.,Intramuscular administration of sodium benzylpenicillin in horses as an alternative to procaine benzylpenicillin. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23419937/),%,100,177812,DB00721,Procaine
,8230402,Cmax,Group 4 single s.c. injections produced a lower mean Cmax (1.85 +/- 0.27 microgram/mL) than the mean Cmax (4.24 +/- 1.08 micrograms/mL) produced in group 3 by i.m. injections into the neck muscle or the mean Cmax (2.63 +/- 0.27 microgram/mL) produced in group 2 by i.m. injections into the gluteal muscle.,A study of the disposition of procaine penicillin G in feedlot steers following intramuscular and subcutaneous injection. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230402/),[μg] / [ml],1.85,180725,DB00721,Procaine
,8230402,Cmax,Group 4 single s.c. injections produced a lower mean Cmax (1.85 +/- 0.27 microgram/mL) than the mean Cmax (4.24 +/- 1.08 micrograms/mL) produced in group 3 by i.m. injections into the neck muscle or the mean Cmax (2.63 +/- 0.27 microgram/mL) produced in group 2 by i.m. injections into the gluteal muscle.,A study of the disposition of procaine penicillin G in feedlot steers following intramuscular and subcutaneous injection. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230402/),[μg] / [ml],4.24,180726,DB00721,Procaine
,8230402,Cmax,Group 4 single s.c. injections produced a lower mean Cmax (1.85 +/- 0.27 microgram/mL) than the mean Cmax (4.24 +/- 1.08 micrograms/mL) produced in group 3 by i.m. injections into the neck muscle or the mean Cmax (2.63 +/- 0.27 microgram/mL) produced in group 2 by i.m. injections into the gluteal muscle.,A study of the disposition of procaine penicillin G in feedlot steers following intramuscular and subcutaneous injection. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230402/),[μg] / [ml],2.63,180727,DB00721,Procaine
,8230402,disappearance t1/2,"Additionally, the disappearance t1/2 was longer (18.08 h) in group 4 following the s.c. injection and shorter (8.85 h) in group 3 following the i.m. neck injection, than the t1/2 following administration of the same dose i.m. into the gluteal muscle (15.96 h) in group 2.",A study of the disposition of procaine penicillin G in feedlot steers following intramuscular and subcutaneous injection. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230402/),h,18.08,180728,DB00721,Procaine
,8230402,disappearance t1/2,"Additionally, the disappearance t1/2 was longer (18.08 h) in group 4 following the s.c. injection and shorter (8.85 h) in group 3 following the i.m. neck injection, than the t1/2 following administration of the same dose i.m. into the gluteal muscle (15.96 h) in group 2.",A study of the disposition of procaine penicillin G in feedlot steers following intramuscular and subcutaneous injection. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230402/),h,8.85,180729,DB00721,Procaine
,8230402,t1/2,"Additionally, the disappearance t1/2 was longer (18.08 h) in group 4 following the s.c. injection and shorter (8.85 h) in group 3 following the i.m. neck injection, than the t1/2 following administration of the same dose i.m. into the gluteal muscle (15.96 h) in group 2.",A study of the disposition of procaine penicillin G in feedlot steers following intramuscular and subcutaneous injection. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230402/),h,15.96,180730,DB00721,Procaine
,8230402,minimum inhibitory concentration (MIC),"In this study, when procaine penicillin G was injected into the gluteal muscle, doses of 66,000 U/kg were necessary to produce plasma concentrations that were above a minimum inhibitory concentration (MIC) for penicillin G of 1.0 microgram/mL as compared to doses of 24,000 U/kg.",A study of the disposition of procaine penicillin G in feedlot steers following intramuscular and subcutaneous injection. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230402/),[μg] / [ml],1.0,180731,DB00721,Procaine
,7944023,peak plasma concentration,"At a dosage for this combination of 9,000 U/kg IM, and 8,800 U/kg, SC, which are approved label recommendations in Canada, and the United States, respectively, mean (+/- SEM) peak plasma concentration was 0.58 (+/- 0.15) and 0.44 (+/- 0.02) microgram/ml, respectively.","Disposition of penicillin G after administration of benzathine penicillin G, or a combination of benzathine penicillin G and procaine penicillin G in cattle. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7944023/),[μg] / [ml],0.58,184225,DB00721,Procaine
,7944023,peak plasma concentration,"At a dosage for this combination of 9,000 U/kg IM, and 8,800 U/kg, SC, which are approved label recommendations in Canada, and the United States, respectively, mean (+/- SEM) peak plasma concentration was 0.58 (+/- 0.15) and 0.44 (+/- 0.02) microgram/ml, respectively.","Disposition of penicillin G after administration of benzathine penicillin G, or a combination of benzathine penicillin G and procaine penicillin G in cattle. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7944023/),[μg] / [ml],0.44,184226,DB00721,Procaine
,7944023,half-life,"After administration of the combination at dosage of 24,000 U/kg, IM, there was an initial peak plasma concentration at approximately 2 hours; thereafter, plasma concentration decreased slowly, with half-life of 58 hours.","Disposition of penicillin G after administration of benzathine penicillin G, or a combination of benzathine penicillin G and procaine penicillin G in cattle. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7944023/),h,58,184227,DB00721,Procaine
,1808237,Kp,The Kp value increased in the following order; procaine (1.1) less than PABA-Et (1.9) less than lidocaine (2.2) less than PABA-Pr (2.7) less than PABA-Bu (3.6).,Study on brain uptake of local anesthetics in rats. ,Km -Q1,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1808237/),,1.1,198236,DB00721,Procaine
,1808237,Kp,The Kp value increased in the following order; procaine (1.1) less than PABA-Et (1.9) less than lidocaine (2.2) less than PABA-Pr (2.7) less than PABA-Bu (3.6).,Study on brain uptake of local anesthetics in rats. ,Km -Q1,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1808237/),,1.9,198237,DB00721,Procaine
,1808237,Kp,The Kp value increased in the following order; procaine (1.1) less than PABA-Et (1.9) less than lidocaine (2.2) less than PABA-Pr (2.7) less than PABA-Bu (3.6).,Study on brain uptake of local anesthetics in rats. ,Km -Q1,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1808237/),,2.2,198238,DB00721,Procaine
,1808237,Kp,The Kp value increased in the following order; procaine (1.1) less than PABA-Et (1.9) less than lidocaine (2.2) less than PABA-Pr (2.7) less than PABA-Bu (3.6).,Study on brain uptake of local anesthetics in rats. ,Km -Q1,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1808237/),,2.7,198239,DB00721,Procaine
,1808237,Kp,The Kp value increased in the following order; procaine (1.1) less than PABA-Et (1.9) less than lidocaine (2.2) less than PABA-Pr (2.7) less than PABA-Bu (3.6).,Study on brain uptake of local anesthetics in rats. ,Km -Q1,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1808237/),,3.6,198240,DB00721,Procaine
,19646094,C(max),"The mean pharmacokinetic parameters (+/-SD) were: C(max), 5.5 +/- 2.6 microg/mL; T(max), 0.75 +/- 0.27 h; AUC(0-infinity), 10.8 +/- 4.9 microg x h/mL; MRT, 2.2 +/- 0.9 h.",Kinetics and residues after intraperitoneal procaine penicillin G administration in lactating dairy cows. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19646094/),[μg] / [ml],5.5,220578,DB00721,Procaine
,19646094,T(max),"The mean pharmacokinetic parameters (+/-SD) were: C(max), 5.5 +/- 2.6 microg/mL; T(max), 0.75 +/- 0.27 h; AUC(0-infinity), 10.8 +/- 4.9 microg x h/mL; MRT, 2.2 +/- 0.9 h.",Kinetics and residues after intraperitoneal procaine penicillin G administration in lactating dairy cows. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19646094/),h,0.75,220579,DB00721,Procaine
,19646094,AUC(0-infinity),"The mean pharmacokinetic parameters (+/-SD) were: C(max), 5.5 +/- 2.6 microg/mL; T(max), 0.75 +/- 0.27 h; AUC(0-infinity), 10.8 +/- 4.9 microg x h/mL; MRT, 2.2 +/- 0.9 h.",Kinetics and residues after intraperitoneal procaine penicillin G administration in lactating dairy cows. ,AUCinf-Q17,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19646094/),[h·μg] / [ml],10.8,220580,DB00721,Procaine
,19646094,MRT,"The mean pharmacokinetic parameters (+/-SD) were: C(max), 5.5 +/- 2.6 microg/mL; T(max), 0.75 +/- 0.27 h; AUC(0-infinity), 10.8 +/- 4.9 microg x h/mL; MRT, 2.2 +/- 0.9 h.",Kinetics and residues after intraperitoneal procaine penicillin G administration in lactating dairy cows. ,MRT-Q53,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19646094/),h,2.2,220581,DB00721,Procaine
,1000155,t 1/2 alpha,After rapid intravenous injection of procaine HC1 (2.5 mg/Kg) in thoroughbred mares plasma levels of this drug fell rapidly (t 1/2 alpha = 5 min) and then more slowly (t 1/2 beta = 50.2 min).,"A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),min,5,228024,DB00721,Procaine
,1000155,t 1/2 beta,After rapid intravenous injection of procaine HC1 (2.5 mg/Kg) in thoroughbred mares plasma levels of this drug fell rapidly (t 1/2 alpha = 5 min) and then more slowly (t 1/2 beta = 50.2 min).,"A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),min,50.2,228025,DB00721,Procaine
,1000155,apparent Vdbeta,"This model gave an apparent Vdbeta for procaine in the horse of about 3,500 litres.","A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",Vb-Q62,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),l,"3,500",228026,DB00721,Procaine
,1000155,Vdbeta,"Since procaine was about 45% bound to equine plasma protein this gives a true Vdbeta for procaine of about 6,500 litres.","A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",Vb-Q62,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),l,"6,500",228027,DB00721,Procaine
,1000155,half-life,After subcutaneous injection of procaine HC1 (3.3 mg/Kg) plasma levels peaked at about 400 ng/ml and then declined with a half-life of about 75 minutes.,"A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),min,75,228028,DB00721,Procaine
,1000155,K,These data were well fitted by Model I when this was modified to include simple first order absorption (K = 0.048 min-1) from the subcutaneous injection site (Model II).,"A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",ka-Q49,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),1/[min],0.048,228029,DB00721,Procaine
,1000155,half-life,"After intramuscular injection of procaine penicillin (33,000 I.U./Kg) plasma levels reached a peak at about 270 ng/ml and then declined with a half-life of about 9 hours.","A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),h,9,228030,DB00721,Procaine
,1000155,first order rate constant for absorption,These data were approximately fitted by Model II assuming a first order rate constant for absorption of procaine of 0.0024 min-1.,"A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",ka-Q49,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),1/[min],0.0024,228031,DB00721,Procaine
,1000155,+ 1/2,After intramuscular injection of procaine HC1 (10 mg/Kg) plasma levels of procaine peaked rapidly at about 600 ng/ml but thereafter declined slowly (+ 1/2 = 2 hours).,"A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),,2,228032,DB00721,Procaine
,1000155,half-life,After intra-articular administration of procaine (0.33 mg/Kg) plasma levels of this drug reached a peak at about 17 ng/ml and then declined with a half-life of about 2 hours.,"A review of the pharmacology, pharmacokinetics and behavioral effects of procaine in thoroughbred horses. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1000155/),h,2,228033,DB00721,Procaine
,8971672,peak concentrations,"Mean peak concentrations of ampicillin in TCF were 7.3 micrograms/mL, reached at 1.7 h, and 1.3 micrograms/mL, reached at 2.7 h, after administration of ampicillin sodium and pivampicillin respectively.",Distribution of penicillins into subcutaneous tissue chambers in ponies. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8971672/),[μg] / [ml],7.3,249524,DB00721,Procaine
,8971672,peak concentrations,"Mean peak concentrations of ampicillin in TCF were 7.3 micrograms/mL, reached at 1.7 h, and 1.3 micrograms/mL, reached at 2.7 h, after administration of ampicillin sodium and pivampicillin respectively.",Distribution of penicillins into subcutaneous tissue chambers in ponies. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8971672/),[μg] / [ml],1.3,249525,DB00721,Procaine
,8971672,peak concentration,The mean peak concentration of penicillin G of 0.3 microgram/mL was reached 12.3 h after administration of procaine penicillin G.,Distribution of penicillins into subcutaneous tissue chambers in ponies. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8971672/),[μg] / [ml],0.3,249526,DB00721,Procaine
,8150879,extraction yield,"The extraction yield of bupivacaine from plasma was 73.5 +/- 5.1% (mean +/- S.D., n = 10).",High-performance liquid chromatographic determination of bupivacaine in plasma samples for biopharmaceutical studies and application to seven other local anaesthetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8150879/),%,73.5,253252,DB00721,Procaine
,8150879,signal-to-noise ratio,"The limit of detection, defined by a signal-to-noise ratio of 3:1, was 2 ng/ml.",High-performance liquid chromatographic determination of bupivacaine in plasma samples for biopharmaceutical studies and application to seven other local anaesthetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8150879/),[ng] / [ml],3:1,253253,DB00721,Procaine
,8150879,signal-to-noise ratio,"The limit of detection, defined by a signal-to-noise ratio of 3:1, was 2 ng/ml.",High-performance liquid chromatographic determination of bupivacaine in plasma samples for biopharmaceutical studies and application to seven other local anaesthetics. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8150879/),[ng] / [ml],2,253254,DB00721,Procaine
,458558,total body clearances (ClT),"The total body clearances (ClT) of PA in slow and fast acetylators were 22.6 and 34.8 liters/hr, respectively.",Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/458558/),[l] / [h],22.6,267921,DB00721,Procaine
,458558,total body clearances (ClT),"The total body clearances (ClT) of PA in slow and fast acetylators were 22.6 and 34.8 liters/hr, respectively.",Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/458558/),[l] / [h],34.8,267922,DB00721,Procaine
,458558,fraction of,The fraction of PA cleared by the formation of NAPA in the corresponding acetylator group was 0.2 and 0.4.,Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/458558/),,0.2,267923,DB00721,Procaine
,458558,fraction of,The fraction of PA cleared by the formation of NAPA in the corresponding acetylator group was 0.2 and 0.4.,Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/458558/),,0.4,267924,DB00721,Procaine
,458558,ClT's,"Renal impairment affected the pharmacokinetics of PA more profoundly as the ClT's of PA in patients with and without renal impairment were 17.9 and 31.2 liters/hr, respectively.",Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/458558/),[l] / [h],17.9,267925,DB00721,Procaine
,458558,ClT's,"Renal impairment affected the pharmacokinetics of PA more profoundly as the ClT's of PA in patients with and without renal impairment were 17.9 and 31.2 liters/hr, respectively.",Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/458558/),[l] / [h],31.2,267926,DB00721,Procaine
